SurModics, Inc.
SRDX
$27.09
$0.331.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.12% | -2.06% | 18.80% | -42.19% | 17.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.12% | -2.06% | 18.80% | -42.19% | 17.50% |
| Cost of Revenue | -6.54% | -6.30% | 33.07% | 0.33% | -7.14% |
| Gross Profit | -18.73% | 3.60% | -7.99% | -64.67% | 71.37% |
| SG&A Expenses | -4.19% | 2.69% | -15.05% | 29.15% | 0.97% |
| Depreciation & Amortization | -2.63% | -0.80% | 0.80% | -1.02% | 1.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.44% | -2.50% | -0.92% | 11.92% | -3.68% |
| Operating Income | -329.14% | 43.79% | 226.00% | -126.09% | 112.44% |
| Income Before Tax | -2,920.48% | -306.63% | 59.23% | -128.14% | 102.25% |
| Income Tax Expenses | 750.62% | 1,040.32% | 124.38% | -86.90% | -122.01% |
| Earnings from Continuing Operations | -2,208.91% | -364.50% | -151.52% | -202.83% | 103.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,208.91% | -364.50% | -151.52% | -202.83% | 103.19% |
| EBIT | -329.14% | 43.79% | 226.00% | -126.09% | 112.44% |
| EBITDA | -77.17% | -5.42% | 1,883.62% | -114.27% | 185.93% |
| EPS Basic | -2,184.57% | -360.68% | -151.07% | -201.97% | 103.17% |
| Normalized Basic EPS | -1,408.22% | 11.84% | 191.05% | -129.08% | 102.70% |
| EPS Diluted | -2,184.57% | -333.33% | -152.55% | -202.52% | 103.17% |
| Normalized Diluted EPS | -1,408.22% | 11.84% | 191.64% | -129.13% | 102.70% |
| Average Basic Shares Outstanding | 0.89% | 0.91% | 0.90% | 0.85% | 0.87% |
| Average Diluted Shares Outstanding | 0.68% | 0.91% | 0.26% | 0.70% | 1.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |